Correlation Between Novo Nordisk and BIORA THERAPEUTNEW

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and BIORA THERAPEUTNEW at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and BIORA THERAPEUTNEW into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and BIORA THERAPEUTNEW 001, you can compare the effects of market volatilities on Novo Nordisk and BIORA THERAPEUTNEW and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of BIORA THERAPEUTNEW. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and BIORA THERAPEUTNEW.

Diversification Opportunities for Novo Nordisk and BIORA THERAPEUTNEW

-0.65

Correlation Coefficient

Novo Nordisk  BIORA THERAPEUTNEW

Excellent diversification

The 3 months correlation between Novo and BIORA is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and BIORA THERAPEUTNEW 001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BIORA THERAPEUTNEW 001 and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with BIORA THERAPEUTNEW. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BIORA THERAPEUTNEW 001 has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and BIORA THERAPEUTNEW go up and down completely randomly.

Pair Corralation between Novo Nordisk and BIORA THERAPEUTNEW

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the BIORA THERAPEUTNEW. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 43.36 times less risky than BIORA THERAPEUTNEW. The stock trades about -0.09 of its potential returns per unit of risk. The BIORA THERAPEUTNEW 001 is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  4.36  in BIORA THERAPEUTNEW 001 on September 28, 2024 and sell it today you would earn a total of  505.64  from holding BIORA THERAPEUTNEW 001 or generate 11597.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	93.55%
Values	Daily Returns

Novo Nordisk AS  vs.  BIORA THERAPEUTNEW 001

Novo Nordisk AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

BIORA THERAPEUTNEW 001

Risk-Adjusted Performance

0 of 100

OK

Over the last 90 days BIORA THERAPEUTNEW 001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, BIORA THERAPEUTNEW reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Novo Nordisk and BIORA THERAPEUTNEW

The main advantage of trading using opposite Novo Nordisk and BIORA THERAPEUTNEW positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, BIORA THERAPEUTNEW can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIORA THERAPEUTNEW will offset losses from the drop in BIORA THERAPEUTNEW's long position.

The idea behind Novo Nordisk AS and BIORA THERAPEUTNEW 001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.